Neuronetics Announced That Humana Has Become The First Commercial Payer To Address TMS Therapy Coverage For Adolescents
Portfolio Pulse from Benzinga Newsdesk
Neuronetics announced that Humana has become the first commercial payer to address TMS therapy coverage for adolescents.
May 15, 2024 | 11:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Humana has become the first commercial payer to address TMS therapy coverage for adolescents, which could enhance its service offerings and attract more customers.
Humana's decision to cover TMS therapy for adolescents could make its insurance plans more attractive to families seeking mental health treatments, potentially increasing its customer base and revenue.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Neuronetics announced that Humana will cover TMS therapy for adolescents, which could increase the adoption of Neuronetics' TMS therapy devices.
With Humana covering TMS therapy for adolescents, Neuronetics could see increased demand for its TMS therapy devices, positively impacting its sales and market presence.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90